We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$18.7B
Cap. Flow
-$13.8B
Cap. Flow %
-10.35%
Top 10 Hldgs %
29.65%
Holding
5,915
New
337
Increased
1,382
Reduced
3,110
Closed
265

Sector Composition

Rank Sector Weight
1 Technology 12.02%
2 Healthcare 5.4%
3 Consumer Discretionary 4.87%
4 Financials 4.64%
5 Industrials 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMBK icon
4601
SmartFinancial
SMBK
$908M
$3.23K ﹤0.01%
151
-4,948
-97% -$114K
AVIR icon
4602
Atea Pharmaceuticals
AVIR
$361M
$3.23K ﹤0.01%
1,075
-40,729
-97% -$139K
NIU
4603
Niu Technologies
NIU
$208M
$3.21K ﹤0.01%
1,133
+198
+21% +$690
EGRX
4604
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.2K ﹤0.01%
203
-5,834
-97% -$105K
GBIO
4605
DELISTED
Generation Bio
GBIO
$3.19K ﹤0.01%
84
-1,376
-94% -$65.2K
HTZWW
4606
CALL
Hertz Global Holdings Warrants
HTZWW
$71.1M
$3.18K ﹤0.01%
520
NTLA icon
4607
CALL
Intellia Therapeutics
NTLA
$1.52B
$3.16K ﹤0.01%
+100
New +$3.88K
ELTX icon
4608
Elicio Therapeutics
ELTX
$77.5M
$3.16K ﹤0.01%
374
BTMD icon
4609
Biote Corp
BTMD
$67.9M
$3.15K ﹤0.01%
615
-3,553
-85% -$20.9K
PLX icon
4610
Protalix BioTherapeutics
PLX
$188M
$3.14K ﹤0.01%
1,893
-16,550
-90% -$29.7K
TRUE
4611
DELISTED
TrueCar
TRUE
$3.11K ﹤0.01%
1,501
-25,767
-94% -$59.1K
NVGS icon
4612
Navigator Holdings
NVGS
$1.34B
$3.1K ﹤0.01%
210
+188
+855% +$2.6K
SKF icon
4613
ProShares UltraShort Financials
SKF
$10M
$3.08K ﹤0.01%
41
ADV icon
4614
Advantage Solutions
ADV
$542M
$3.08K ﹤0.01%
43
-1,026
-96% -$68.1K
DM
4615
DELISTED
Desktop Metal, Inc.
DM
$3.08K ﹤0.01%
211
-290,148
-100% -$4.82M
PLG
4616
Platinum Group Metals
PLG
$159M
$3.08K ﹤0.01%
2,700
ARIS
4617
DELISTED
Aris Water Solutions
ARIS
$3.07K ﹤0.01%
308
-8,676
-97% -$92.4K
KRMA
4618
DELISTED
Global X Conscious Companies ETF
KRMA
$3.05K ﹤0.01%
102
+2
+2% +$62
CCNE icon
4619
CNB Financial Corp
CCNE
$1.05B
$3.04K ﹤0.01%
168
-6,028
-97% -$112K
SLNO
4620
DELISTED
Soleno Therapeutics
SLNO
$3.04K ﹤0.01%
+103
New +$623
WE
4621
DELISTED
WeWork Inc.
WE
$2.98K ﹤0.01%
990
+964
+3,708% +$6.62K
BBCP icon
4622
Concrete Pumping Holdings
BBCP
$513M
$2.97K ﹤0.01%
346
-7,410
-96% -$59.7K
PPTA
4623
Perpetua Resources
PPTA
$2.18B
$2.96K ﹤0.01%
903
-10,345
-92% -$36.3K
MPB icon
4624
Mid Penn Bancorp
MPB
$972M
$2.96K ﹤0.01%
147
-4,442
-97% -$98.4K
ATAI icon
4625
AtaiBeckley Inc
ATAI
$2.66B
$2.95K ﹤0.01%
2,288
-8,295
-78% -$14.2K

Similar funds

Citigroup's Q3 2023 Portfolio in Review

As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.

  • Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
  • Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
  • Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
  • Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
  • Citigroup opened 337 new positions and closed 265 in Q3 2023.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.